Centre for Women's Health

1999 Publications

Book Chapters: DETYA
Salamonsen^*, L.A., Kovacs, G. and Findlay^*, J.K., ‘Current concepts of the mechanisms of menstruation’, Clinical Obstetrics & Gynaecology, Bailliere Tindall, London, UK, 161 - 180, in S Arulkumaran (ed)

Venn^*, A., Watson^*, L., Giles^*, G.G. and Healy^‡, D., ‘Breast, ovarian and uterine cancer in 29,700 Australian IVF patients.  Fertility & Genetics beyond 1999’, Towards Reproductive Certainty, The Parthenon Publishing Group, London, 109 - 115, in Robert Jansen & David Mortimer (ed), 1999

Journal Article: refereed articles in a scholarly journal
Abberton^†, K.M., Taylor, N., Healy, D. and Rogers, P.A., ‘Vascular smooth muscle cell proliferation in arterioles of the human endometrium’, Human Reproduction, Oxford Univ Press, Oxford, England, 14;4, 1072 - 1079

Abberton^†, K.M., Healy, D. and Rogers, P.A., ‘Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles’, Human Reproduction, Oxford Univ Press, Oxford, England, 14;12, 3095 - 3100

Audrins^*, P., Holden^*, C.A., McLachlan^*, R. and Kovacs, G., ‘Semen storage for special purposes at Monash IVF 1977 to 1997’, Fertility and Sterility, Elsevier Science Inc, New York, USA, 72;1, 179 - 181

Dwyer^*, P.L., Carey^*, M.P. and Rosamilia^†, A., ‘Suture injury to the urinary tract in urethral suspension procedures for stress incontinence’, International Urogynecology Journal, Springer-Verlag, London, UK, 10, 15 - 21

Fuller^*, P.J., Chu^*, S., Jobling, T., Mamers, P., Healy, D. and Burger^*, H., ‘Inhibin subunit gene expression in ovarian cancer’, Gynecologic Oncology, Academic Press Inc, San Diego, CA, 73, 273 - 279

Gargett, C., Lederman, F., Lau, T.M., Taylor, N. and Rogers, P.A., ‘Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium’, Human Reproduction, Oxford Univ Press, Oxford, England, 14;8, 2080 - 2088

Harris^*, G.M., Stendt^*, C.L., Vollenhoven, B., Eng Gan^*, T. and Tipping^‡, P.G., ‘Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives’, American Journal of Hematology, Wiley-Liss, New York, USA., 60, 175 - 180

Kothari^*, A., Bethune^*, M., Manwaring^*, J., Astley^*, N. and Wallace, E.M., ‘Massive bilateral phaeochromocytomas in association with Von Hippel Lindau Syndrome in pregnancy’, Aust NZ J Obstet Gynaecol, Australian NA J Obstet Gynaec, East Melbourne, Australia, 39;3, 381 - 384

Kovacs, G., ‘What factors are important for successful embryo transfer after in-vitro fertilization?’, Human Reproduction, Oxford Univ Press, Oxford, England, 14;3, 590 - 592

Meachem^†, S.J., McLachlan^*, R., Stanton^*, P.G., Robertson^*, D.M. and Wreford^*, N.G., ‘FSH immunoneutralization acutely impairs spermatogonial development in normal adult rats’, Journal of Andrology, Amer Soc Andrology, Inc, Lawrence, KS, 20, 756 - 762

Mirza^*, T., Kovacs, G. and McDonald^*, P., ‘The use of family planning services by non-english speaking background (NESB) women’, Aust NZ J Obstet Gynaecol, Australian NZ J Obstet Gynaec, East Melbourne, Australia, 39;3, 58 - 62

Orre^†, M. and Rogers, P.A., ‘Macrophages and microvessel density in tumors of the ovary’, Gynecologic Oncology, Academic Press Inc., USA, 73, 47 - 50

Orre^†, M. and Rogers, P.A., ‘VEGF, VEGFR-1, VEGFR-2 microvessel density and endothelial cell proliferation in tumours of the ovary’, International Journal of Cancer, Wiley-Liss, Div John Wiley & Sons Inc., New York, USA, 84, 101 - 108

Orre^†, M., Susil^*, B. and Rogers, P.A., ‘Microvessel density and vasular basement membrane immunostaining in tumours of the breast’, Angiogenesis, Kluwer Academic Publishers, The Netherlands, Vol 3, 175 - 180

Out^*, H.J., Lindenberg^*, S., Mikkelsen^*, A.L., Eldar-Geva^*, T., Healy^‡, D., Leader^*, A., Rodriguez-Escudero^*, F.J., Garcia-Velasco^*, J.A. and Pellicer^*, A., ‘A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation’, Human Reproduction, Oxford Univ Press, Oxford, England, 14;3, 622 - 627

Robertson^*, D.M., Cahir^*, N., Burger^*, H., Mamers, P., McCloud^‡, P., Pettersson^*, K. and McGuckin^*, M., ‘Combined inhibin and CA125 assays in the detection of ovarian cancer’, Clinical Chemistry, Am Assoc Clinical Chemistry, Washington, DC, 45;5, 651 - 658

Robertson^*, D.M., Cahir^*, N., Burger^*, H., Mamers, P. and Groome^*, N., ‘Inhibin forms in serum from postmenopausal women with ovarian cancers’, Clinical Endocrinology, Blackwell Science Ltd, Oxford, England, 50, 381 - 386

Rogers, P.A. and Gargett, C., ‘Endometrial angiogenesis’, Angiogenesis, Kluwer Academic Publishers, The Netherlands, 2;4, 287 - 294

Rosamilia^†, A., Cann, L., Dwyer^*, P.L., Scurry^*, J. and Rogers, P.A., ‘Bladder microvasculature in women with interstitial cystitis’, Journal of Urology, Lippincott Williams & Wilkins, Philadelphia, PA, 161, 1866 - 1870

Rosamilia^†, A., Clements^*, J., Dwyer^*, P.L., Kende^*, M. and Campbell^*, D.J., ‘Activation of the Kallikrein Kinnin system in interstitial cystitis’, Journal of Urology, Lippincott Williams & Wilkins, Philadelphia, PA, 162, 129 - 134

Shehata^*, N., Burrows, R.F. and Kelton^*, J.G., ‘Gestational Thrombocytopenia’, Clinical Obstetrics & Gynecology, Lippincott Williams & Wilkins, Inc., Philadelphia, USA, RM Pitkin, JR Scott, 327 - 334, Vol 42; No 2

Venn^*, A., Watson^*, L., Bruinsma^*, F., Giles^*, G.G. and Healy^‡, D., ‘Risk of cancer after use of fertility drugs with in-vitro fertilisation’, The Lancet, Lancet Ltd, London, England, 354, 1586 - 1590

Vincent^†, A.J., Malakooti^*, N., Zhang^*, J., Rogers, P.A., Affandi^*, B. and Salamonsen, L.A., ‘Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinease B)*’, Human Reproduction, Oxford Univ Press, Oxford, England, 14;3, 807 - 815

Wallace, E.M. and Baker^*, L.S., ‘Effect of antenatal betamethasone administration on placental vascular resistance’, The Lancet, Lancet Ltd, London, UK, 353, 1404 - 1407

Wallace, E.M., D'Antona, D., Shearing^*, C.H., Evans^*, L.W., Thirunavukarasu^†, P., Ashby^*, P.J., Shade^*, M. and Groome^*, N.P., ‘Amniotic fluid levels of dimeric inhigins, pro-ac inhibin, activin A and follistatin in Down's syndrome’, Clinical Endocrinology, Blackwell Science Ltd, Oxford, UK, 50, 669 - 673

Wood, C., ‘Future change in sexual behaviour?’, Medical Journal of Australia, Australasian Med Publ Co Ltd, Sydney, 171, 662 - 664